CCR2 and benign neoplasm: Nevertheless a distinct contribution of macrophage subsets to the outcome of lymphatic remodeling was provided by CCR2 antagonist treatment that preserved cardiac macrophage subsets ratio and reduced lymphatic remodeling within the hypertrophic heart.